Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model

Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Strakova, 2008, Multipotent properties of myofibroblast cells derived from human placenta, Cell and Tissue Research, 332, 479, 10.1007/s00441-008-0604-x Lin, 2006, Pluripotency potential of human adipose-derived stem cells marked with exogenous green fluorescent protein, Molecular and Cellular Biochemistry, 291, 1, 10.1007/s11010-006-9188-5 Sun, 2007, Regulation of human umbilical cord blood-derived multi-potent stem cells by autogenic osteoclast-based niche-like structure, Biochemical and Biophysical Research Communications, 357, 92, 10.1016/j.bbrc.2007.03.072 Kim, 2004, Mesenchymal progenitor cells in the human umbilical cord, Annals of Hematology, 83, 733, 10.1007/s00277-004-0918-z Laird, 2008, Stem cell trafficking in tissue development, growth, and disease, Cell, 132, 612, 10.1016/j.cell.2008.01.041 Chamberlain, 2007, Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing, Stem Cells, 25, 2739, 10.1634/stemcells.2007-0197 Ren, 2008, Cancer gene therapy using mesenchymal stem cells expressing interferon-[beta] in a mouse prostate cancer lung metastasis model, Gene Ther, 15, 1446, 10.1038/gt.2008.101 Hsu, 2008, Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model, J Bone Joint Surg Am, 90, 1043, 10.2106/JBJS.G.00292 Finney, 2006, Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia, Biology of Blood and Marrow Transplantation, 12, 585, 10.1016/j.bbmt.2005.12.037 Nauta, 2007, Immunomodulatory properties of mesenchymal stromal cells, Blood, 110, 3499, 10.1182/blood-2007-02-069716 Lin, 2007, Isolation and identification of mesenchymal stem cells from human lipoma tissue, Biochemical and Biophysical Research Communications, 361, 883, 10.1016/j.bbrc.2007.07.116 Kern, 2006, Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue, Stem Cells, 24, 1294, 10.1634/stemcells.2005-0342 Wagner, 2005, Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood, Experimental Hematology, 33, 1402, 10.1016/j.exphem.2005.07.003 Bissell, 2001, Putting tumours in context, Nat Rev Cancer, 1, 46, 10.1038/35094059 Park, 2000, The influence of the microenvironment on the malignant phenotype, Molecular Medicine Today, 6, 324, 10.1016/S1357-4310(00)01756-1 Khakoo, 2006, Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma, J Exp Med, 203, 1235, 10.1084/jem.20051921 Ren, 2008, Therapeutic potential of mesenchymal stem cells producing IFN-α in a mouse melanoma lung metastasis model, Stem Cells, 26, 2332, 10.1634/stemcells.2008-0084 Karnoub, 2007, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, 449, 557, 10.1038/nature06188 Chang, 2006, Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood, Stem Cells, 24, 679, 10.1634/stemcells.2004-0308 Park, 2008, The roles of wnt antagonists dkk1 and sfrp4 during adipogenesis of human adipose tissue-derived mesenchymal stem cells, Cell Proliferation, 41, 859, 10.1111/j.1365-2184.2008.00565.x Ghodsizad, 2009, Transplanted human cord blood derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction, Heart, 95, 27, 10.1136/hrt.2007.139329 Wang, 2008, The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro, Immunology, 126, 220, 10.1111/j.1365-2567.2008.02891.x Kim, 2007, Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model, Brain Res, 1183, 43, 10.1016/j.brainres.2007.09.005 Sasser, 2007, Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3d tumor environments, Cancer Lett, 254, 255, 10.1016/j.canlet.2007.03.012 Zhu, 2006, Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo, Exp Mol Pathol, 80, 267, 10.1016/j.yexmp.2005.07.004 Lazennec, 2008, Concise review. Adult multipotent stromal cells and cancer: risk or benefit?, Stem Cells, 26, 1387, 10.1634/stemcells.2007-1006 Hurst, 2007, A msc-ing link in metastasis?, Nat Med, 13, 1289, 10.1038/nm1107-1289 Maestroni, 1999, Factor(s) from nonmacrophage bone marrow stromal cells inhibit lewis lung carcinoma and b16 melanoma growth in mice, Cell Mol Life Sci, 55, 663, 10.1007/s000180050322 Ohlsson, 2003, Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix, Exp Mol Pathol, 75, 248, 10.1016/j.yexmp.2003.06.001 Komarova, 2006, Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses, Mol Cancer Ther, 5, 755, 10.1158/1535-7163.MCT-05-0334 Studeny, 2002, Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors, Cancer Res, 62, 3603 Studeny, 2004, Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents, J Natl Cancer Inst, 96, 1593, 10.1093/jnci/djh299 Kucerova, 2007, Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy, Cancer Res, 67, 6304, 10.1158/0008-5472.CAN-06-4024 Kyriakou, 2006, Human mesenchymal stem cells (hmscs) expressing truncated soluble vascular endothelial growth factor receptor (tsflk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model, The Journal of Gene Medicine, 8, 253, 10.1002/jgm.840 Gunn, 2006, A crosstalk between myeloma cells and marrow stromal cells stimulates production of dkk1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma, Stem Cells, 24, 986, 10.1634/stemcells.2005-0220 Sasser, 2007, Interleukin-6 is a potent growth factor for ER-(-positive human breast cancer, FASEB J, 21, 3763, 10.1096/fj.07-8832com Ramasamy, 2006, Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth, Leukemia, 21, 304, 10.1038/sj.leu.2404489